Inflammatory bowel disease (ulcerative colitis): Clinical sciences

2,358views

test

00:00 / 00:00

Inflammatory bowel disease (ulcerative colitis): Clinical sciences

Focused chief complaint

Abdominal pain

Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Acute coronary syndrome: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Adnexal torsion: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Aortic dissection: Clinical sciences
Appendicitis: Clinical sciences
Approach to ascites: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Chronic pancreatitis: Clinical sciences
Colonic volvulus: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Diverticulitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Endometriosis: Clinical sciences
Gastritis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Ileus: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inguinal hernias: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Lower urinary tract infection: Clinical sciences
Malaria: Clinical sciences
Nephrolithiasis: Clinical sciences
Paraesophageal and hiatal hernia: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pulmonary embolism: Clinical sciences
Pyelonephritis: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Sickle cell disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences

Altered mental status

Approach to altered mental status: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to hypocalcemia: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to schizophrenia spectrum and other psychotic disorders: Clinical sciences
Approach to shock: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Delirium: Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Hypothermia: Clinical sciences
Hypovolemic shock: Clinical sciences
Lower urinary tract infection: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Pyelonephritis: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Substance use disorder: Clinical sciences
Uremic encephalopathy: Clinical sciences

Assessments

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

A 52-year-old woman presents to the primary care clinic because of a 3-month history of bloody diarrhea, crampy abdominal pain, and tenesmus. Her symptoms have been progressing and she has been having 5 episodes of loose bloody stool per day for the past month. Past medical history is significant for type 2 diabetes mellitus. Temperature is 37.3 °C (99.1 °F), blood pressure is 142/85, pulse is 92/min, and respiratory rate is 18/min. The patient appears comfortable. Physical examination is significant for moderate abdominal tenderness on palpation and bright red blood on digital rectal exam. Laboratory findings are significant for a hemoglobin of 10.3 g/dL and an elevated CRP. Stool studies are negative for infectious etiologies. Fecal calprotectin is positive. A colonoscopy reveals a continuous pattern of erythema, friability, and ulcerations in the rectum and sigmoid colon. Histopathological examination reveals mucosal and submucosal chronic inflammation, and crypt abscesses consistent with the diagnosis of ulcerative colitis. Which of the following medications should be administered to induce remission in this patient?  

Transcript

Watch video only

Inflammatory bowel disease, or IBD, is a condition characterized by chronic gastrointestinal tract inflammation. It can be subdivided into Ulcerative Colitis and Crohn Disease.

Ulcerative Colitis, or UC, primarily affects the colon and is characterized by continuous ulcerations of the mucosa and submucosa, which may lead to abdominal pain, bloody diarrhea, and tenesmus. Management is based on the severity of disease and they can be categorized as mild to moderate, moderate to severe, or acute severe.

Now, when assessing an individual with suspected ulcerative colitis, you should first perform an ABCDE assessment to determine if they are stable or unstable. Unstable individuals might present with signs of shock, like tachycardia and hypotension, so you might have to secure their airway, breathing, and circulation before further workup. Unstable patients may also have signs of complications like toxic megacolon, perforated colon, or severe refractory hemorrhage. These patients should be hospitalized, and given intravenous fluids and antibiotics.

Once they are stable, you should find out what caused the instability. If the patient presents with pallor and profuse rectal bleeding, consider anemia and hypovolemic shock due to severe refractory hemorrhage. In this situation, begin systemic corticosteroids and transfuse blood products. If the abdomen is distended or firm, consider toxic megacolon. An X-ray might reveal an enlarged colon and possibly signs of perforation, like pneumoperitoneum.

These patients should also have stool studies to rule out C. difficile infection. A high yield fact to keep in mind about unstable patients is that you should avoid colonoscopy because there is a high risk of colon perforation. If an unstable patient has evidence of severe refractory hemorrhage, toxic megacolon, or perforated viscus, you can consult surgery for possible colectomy.

Now, when it comes to stable individuals, the first step is to obtain a focused history and physical exam. History typically reveals diffuse or periumbilical crampy abdominal pain, bloody diarrhea, tenesmus, and fecal urgency. Some patients report extra-intestinal symptoms, like eye pain, joint pain, and rashes.

Physical exam usually reveals an abdomen that’s tender to palpation. Additionally, there might be extra-intestinal manifestations, such as eye findings like uveitis and episcleritis; skin findings like tender red spots that indicate erythema nodosum and painful ulcerations associated with pyoderma gangrenosum; or even jaundice that might point to Primary Sclerosing Cholangitis. Finally, the rectal exam might reveal bright red blood and discomfort on palpation.

Now, to differentiate IBD from other diagnoses with similar presentations, such as Irritable Bowel Syndrome or IBS and C.difficile colitis, you should obtain stool laboratory studies. Fecal calprotectin is a marker of colon inflammation. Since IBS does not cause colon inflammation, a positive fecal calprotectin would increase your suspicion for IBD. Similarly, negative stool studies for pathogens help rule out infectious etiologies like C.difficile colitis. Next, you should check blood work, which may reveal anemia and elevated inflammatory markers such as CRP and ESR.

If the H&P, imaging, and lab findings suggest IBD, the next step is to confirm the diagnosis with a colonoscopy with biopsies. On colonoscopy, you may observe erythema, a decreased or absent vascular pattern, friability, and ulcerations in a continuous pattern.

UC usually starts in the rectum, which is called proctitis, and typically progresses to the splenic flexure, which is referred to as left-sided colitis. Sometimes it can extend beyond the splenic flexure, which is then called extensive colitis. Some individuals develop inflammation just beyond the ileocecal valve, called backwash ileitis, so don’t forget to visualize the ileum during colonoscopy.

Biopsy of the ileum with histopathologic evaluation will help differentiate UC from Crohn Disease, in which the ileum is the most commonly affected segment of the GI tract. Typical histopathologic findings of UC on biopsy include mucosal and submucosal chronic inflammation, erosions, ulcerations, and crypt abscesses.

After you confirm the diagnosis of UC with colonoscopy, you should determine the severity of the disease based on signs and symptoms like frequency of stools per day, amount of blood in the stool, the presence of cramps and tenesmus, amount of weight loss, and colonoscopy findings. Using these findings, UC can be broken down into three categories: mild to moderate, moderate to severe, and acute severe ulcerative colitis.

Sources

  1. "A Review of Four Practice Guidelines of Inflammatory Bowel Disease" Cureus (2021)
  2. "AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis" Gastroenterology (2020)
  3. "ACG Clinical Guideline: Ulcerative Colitis in Adults" American Journal of Gastroenterology (2019)
  4. " I have a patient with unintentional weight loss. How do I determine the cause?" Symptom to Diagnosis an Evidence Based Guide (2020)
  5. "Diarrhea" CDIM Core Medicine Clerkship Curriculum Guide, 4th ed (2020)
  6. "AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis" Gastroenterology (2019)
  7. "The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017" Lancet Gastroenterol Hepatol (2020)